Literature DB >> 9247481

Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice.

N Furuya1, S Kawa, T Akamatsu, K Furihata.   

Abstract

BACKGROUND & AIMS: Conflicting reports have raised the question whether K-ras gene mutations in chronic pancreatitis are related to the development of pancreatic neoplasm. The aim of the present study was to clarify this issue by surveying patients with chronic pancreatitis and K-ras gene mutation over 4 years.
METHODS: K-ras point mutations at codon 12 in duodenal juices obtained during exocrine function tests were examined by enriched polymerase chain reaction-restriction fragment length polymorphism and direct DNA sequence analysis, and long-term follow-up of these patients was performed.
RESULTS: K-ras gene mutation was found in 20 of 54 patients (37%) with chronic pancreatitis. The types of mutation were GAT in 7, GTT in 11, and TGT in 2 patients. Pancreatic neoplasm occurred in none of the mutation-positive patients over a mean follow-up period of 78 months.
CONCLUSIONS: K-ras gene mutation in patients with chronic pencreatitis did not seem to be related to the development of pancreatic neoplasm during the follow-up period, and analysis of K-ras gene mutation seems of little use for diagnosing pancreatic neoplasm in patients with chronic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247481     DOI: 10.1053/gast.1997.v113.pm9247481

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

1.  Advances in molecular genetics for the pancreatologist.

Authors:  L J Miller
Journal:  Curr Gastroenterol Rep       Date:  1999-04

Review 2.  Chemoprevention for pancreatic cancer.

Authors:  Robert A Wolff
Journal:  Int J Gastrointest Cancer       Date:  2003

3.  Detection of oncogenes in chronic pancreatitis.

Authors:  D Paramythiotis; J Kleeff; J Schmidt; M W Büchler; H Friess
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

4.  Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis.

Authors:  Renata Talar-Wojnarowska; Anita Gasiorowska; Beata Smolarz; Hanna Romanowicz-Makowska; Janusz Strzelczyk; Adam Janiak; Andrzej Kulig; Ewa Malecka-Panas
Journal:  Int J Gastrointest Cancer       Date:  2005

5.  Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.

Authors:  L Theodor; E Melzer; M Sologov; G Idelman; E Friedman; S Bar-Meir
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

Review 6.  Pancreatic cancer: can we screen? How should we stage?

Authors:  A A Parikh; A M Lowy
Journal:  Curr Gastroenterol Rep       Date:  1999-04

7.  Comparison of the novel quantitative ARMS assay and an enriched PCR-ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses.

Authors:  N T van Heek; S J Clayton; P D J Sturm; J Walker; D J Gouma; L A Noorduyn; G J A Offerhaus; J C Fox
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

8.  Detection of K-ras point mutation and telomerase activity during endoscopic retrograde cholangiopancreatography in diagnosis of pancreatic cancer.

Authors:  Guo-Xiong Zhou; Jie-Fei Huang; Zhao-Shen Li; Guo-Ming Xu; Feng Liu; Hong Zhang
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

Review 9.  Genetic alterations in pancreatic cancer.

Authors:  Muhammad Wasif Saif; Lena Karapanagiotou; Kostas Syrigos
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

Review 10.  Values of mutations of K-ras oncogene at codon 12 in detection of pancreatic cancer: 15-year experience.

Authors:  De-Qing Mu; You-Shu Peng; Qiao-Jian Xu
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.